Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$125.26 - $203.83 $202,545 - $329,593
-1,617 Reduced 19.19%
6,809 $1.39 Million
Q3 2023

Nov 14, 2023

SELL
$185.0 - $326.08 $248,085 - $437,273
-1,341 Reduced 13.73%
8,426 $1.67 Million
Q2 2023

Aug 11, 2023

SELL
$226.52 - $324.64 $12,005 - $17,205
-53 Reduced 0.54%
9,767 $3.17 Million
Q1 2023

May 12, 2023

SELL
$229.06 - $278.01 $1.54 Million - $1.87 Million
-6,721 Reduced 40.63%
9,820 $2.3 Million
Q4 2022

Feb 24, 2023

BUY
$164.02 - $259.76 $1.01 Million - $1.6 Million
6,172 Added 59.52%
16,541 $4.16 Million
Q4 2022

Feb 13, 2023

SELL
$164.02 - $259.76 $61,015 - $96,630
-372 Reduced 3.46%
10,369 $2.61 Million
Q3 2022

Nov 14, 2022

SELL
$170.68 - $226.46 $78,854 - $104,624
-462 Reduced 4.12%
10,741 $1.97 Million
Q2 2022

Aug 12, 2022

BUY
$147.53 - $266.6 $233,982 - $422,827
1,586 Added 16.49%
11,203 $2.04 Million
Q1 2022

May 13, 2022

BUY
$193.94 - $261.91 $1.87 Million - $2.52 Million
9,617 New
9,617 $2.47 Million
Q4 2021

Feb 14, 2022

SELL
$207.57 - $280.17 $2.23 Million - $3.01 Million
-10,726 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$170.0 - $258.58 $133,450 - $202,985
-785 Reduced 6.82%
10,726 $2.5 Million
Q2 2021

Aug 13, 2021

SELL
$164.93 - $242.23 $31,501 - $46,265
-191 Reduced 1.63%
11,511 $2.23 Million
Q1 2021

May 14, 2021

SELL
$182.45 - $249.25 $83,562 - $114,156
-458 Reduced 3.77%
11,702 $2.42 Million
Q4 2020

Feb 12, 2021

SELL
$119.35 - $200.46 $54,542 - $91,610
-457 Reduced 3.62%
12,160 $2.29 Million
Q3 2020

Nov 12, 2020

BUY
$87.5 - $130.91 $1.1 Million - $1.65 Million
12,617 New
12,617 $1.63 Million

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.34B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.